Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11891662 Polynucleotides for amplification and detection of human beta actin

Patent 11891662 was granted and assigned to Talis Biomedical on February, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Talis Biomedical

0

Current Assignee

Talis Biomedical

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Jason M. Casolari0

Hédia Maamar0

Xuewen Jiang0

Date of Patent

February 6, 2024

0

Patent Application Number

167008240

Date Filed

December 2, 2019

0

Patent Citations

US Patent 9434999 Specific detection of organisms derived from a sample

0

US Patent 9982312 Microbial assay

0

US Patent 10252264 Sample preparation module with stepwise pressurization mechanism

0

US Patent 10450616 Polynucleotides for the amplification and detection of

0

US Patent 10954572 Polynucleotides for the amplification and detection of

0

US Patent 11326214 Polynucleotides for the amplification and detection of chlamydia trachomatis

0

US Patent 11047007 Polynucleotides for amplification and detection of SARS-CoV-2

0

US Patent 7504111 Gonococcal proteins and nucleic acids

0

...

Patent Primary Examiner

Suryaprabha Chunduru

0

Patent abstract

Disclosed herein are primers and probes related to the detection of beta actin [

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11891662 Polynucleotides for amplification and detection of human beta actin

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool